HES1 and coronary artery disorder: Abnormal HES1 expression was observed in a variety of CHD types, indicating strong biological sensitivity to HES1 dosage, which has been confirmed in multiple animal models (Yuan et al., 2017; Wu et al., 2018; Zhang et al., 2018).